Forskolin improves sensitivity to doxorubicin of triple negative breast cancer cells via Protein Kinase A-mediated ERK1/2 inhibition

Forskolin improves sensitivity to doxorubicin of triple negative breast cancer cells via Protein Kinase A-mediated ERK1/2 inhibition

Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Biochemical Pharmacology - Volume 152, June 2018, Pages 104-113

Michela Illiano, Luigi Sapio, Alessia Salzillo, Lucia Capasso, Ilaria Caiafa, Emilio Chiosi, Annamaria Spina, Silvio Naviglio,